Literature DB >> 7367036

Multiple intramuscular injections: a major source of variability in analgesic response to meperidine.

K L Austin1, J V Stapleton, L E Mather.   

Abstract

Meperidine (ethidine) blood concentrations following multiple intramuscular injections (100 mg) over 2 days were determined in 10 female patients undergoing elective abdominal hysterectomies or cholecystectomies. Pain was estimated by subjective bioassay and the relationship between concentration and effect determined. The blood concentration-effect curve was steep with the range from no analgesia to complete analgesia being 0.35--0.45 microgram/ml on day 1 and 0.4--0.5 microgram/ml on day 2. The mean (+/- S.D.) minimum analgesic blood concentration was 0.5 +/- 0.1 microgram/ml (n = 32). Pain control was poor during the first 4-h dosing interval. The first injection post-surgery was also found to be the least representative of all subsequent injections. Blood concentrations fluctuated in phase with dosing interval, but were highly variable. Intra- and inter-patient peak concentrations varied by 2- and 5-fold and times taken to reach the peaks by 3- and 7-fold, respectively. Hence, meperidine blood concentrations were in excess of the minimum analgesic concentration for only about 35% of each of each 4-h dosing interval. Peak concentrations were not consistently correlated with body weight or lean tissue mass. Variable pain control following intermittent intramuscular meperidine injections was shown to be due to inadequate, fluctuating and unpredictable blood concentrations.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7367036     DOI: 10.1016/0304-3959(80)90089-5

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  18 in total

Review 1.  Management of post-operative pain.

Authors:  G Smith
Journal:  Can J Anaesth       Date:  1989-05       Impact factor: 5.063

Review 2.  Pharmacokinetic optimisation of opioid treatment in acute pain therapy.

Authors:  R N Upton; T J Semple; P E Macintyre
Journal:  Clin Pharmacokinet       Date:  1997-09       Impact factor: 6.447

3.  Postoperative pulmonary complications. Obesity, pain, and sedation are important.

Authors:  A Higgs
Journal:  BMJ       Date:  1996-05-04

Review 4.  Intravenous anaesthetic agents. Pharmacokinetic-pharmacodynamic relationships.

Authors:  B N Swerdlow; F O Holley
Journal:  Clin Pharmacokinet       Date:  1987-02       Impact factor: 6.447

5.  Strong analgesics in severe pain.

Authors:  G K Gourlay; M J Cousins
Journal:  Drugs       Date:  1984-07       Impact factor: 9.546

6.  Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics.

Authors:  Siew Hua Gan; Rusli Ismail; Wan Aasim Wan Adnan; Wan Zulmi
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

Review 7.  Clinical pharmacokinetics and pharmacodynamics of opioid analgesics in infants and children.

Authors:  K T Olkkola; K Hamunen; E L Maunuksela
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

Review 8.  Obstetric analgesia. Clinical pharmacokinetic considerations.

Authors:  J Kanto
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

9.  Meperidine infusion for postoperative analgesia in grossly obese patients.

Authors:  J S Sprigge; D S East; G S Fox; R I Ogilvie; P E Otton; D R Bevan
Journal:  Can Anaesth Soc J       Date:  1982-03

10.  Cardiopulmonary parameters during meperidine, promethazine, and chlorpromazine sedation for pediatric dentistry.

Authors:  M E Saravia; W R Currie; R L Campbell
Journal:  Anesth Prog       Date:  1987 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.